EODData

MEMBERSHIP REGISTER LOG IN

ASX, CU6: Clarity Pharmaceuticals Ltd.

15 Apr 2026
LAST:

3.140

CHANGE:
 0.23		OPEN:
2.960		HIGH:
3.220		ASK:
3.420		VOLUME:
5.55M
CHG(%):
7.90		PREV:
2.910		LOW:
2.960		BID:
3.370		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
15 Apr 262.9603.2202.9603.1405.55M
14 Apr 263.3003.3052.8202.91010.22M
13 Apr 263.1303.2053.0503.1301.33M
10 Apr 263.1403.2203.0703.1801.34M
09 Apr 263.2203.3003.0903.1401.25M
08 Apr 263.1703.3103.1203.2502.08M
07 Apr 263.1703.2503.0303.0501.56M
02 Apr 263.3503.4103.1503.1501.25M
01 Apr 263.2103.3503.1503.3202.18M
31 Mar 263.0803.1502.9603.1002.31M

PROFILE

Name:Clarity Pharmaceuticals Ltd.
About:Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:National Innovation Centre, Sydney, NSW, Australia, 2015
Website:https://www.claritypharmaceuticals.com
ISIN:AU0000165375
FIGI:BBG011WVJ0K9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-16.72 
Forward P/E:-9.93 
PEG Ratio:-14.51 
Price to Sales:132.10 
Price to Book:5.03 
Operating Margin:-8.23 
Return on Assets:-0.34 
Return on Equity:-0.54 
EPS Ratio:-0.28 
Revenue:9.46M 
Shares:372.26M 
Market Cap:1.169B 

TECHNICAL INDICATORS

MA5:3.101.3%
MA10:3.140.1%
MA20:3.232.8%
MA50:3.325.8%
MA100:3.366.9%
MA200:3.6616.4%
STO9:46.00
STO14:31.08
RSI14:51.60
WPR14:-56.60
MTM14:-0.30
ROC14:-0.09 
ATR:0.27 
Week High:3.315.4%
Week Low:2.8211.3%
Month High:4.2635.7%
Month Low:2.8216.4%
Year High:5.8786.9%
Year Low:1.6887.5%
Volatility:89.71